FKBP10‐high tumors showed enhanced ECM remodeling, metabolic reprogramming, and apoptosis resistance, accompanied by an immunosuppressive microenvironment with reduced cytotoxic T cells and enrichment of myeloid‐derived suppressor cells and cancer‐associated fibroblasts. Here, FKBP10 is linked to cancer.